论文部分内容阅读
目的:探讨与分析贝沙坦联合钙离子拮抗剂治疗老年2型糖尿病并高血压的临床效果。方法:将2011年7月到2013年7月于我院接受治疗的50例2型糖尿病合并高血压的老年患者作为研究对象,按照入院顺序将其分为对照组与观察组各25例,对对照组患者给予厄贝沙坦联合络活喜治疗,对观察组患者则给予厄贝沙坦联合左旋氨氯地平治疗,对比观察两组患者的治疗效果。结果:观察组患者血压下降幅度显著高于对照组患者,组间对比差异显著(P<0.05)。结论:在2型糖尿病并高血压的老年患者的临床治疗中,选用厄贝沙坦联合左旋氨氯地平药物治疗,能够在保障患者正常代谢的前提下,有效降低其血压水平,保护其肾脏功能,且疗效显著,值得推广。
Objective: To investigate and analyze the clinical effect of combining with calcium channel blocker of calcium channel blocker on type 2 diabetes mellitus and hypertension in the elderly. Methods: From July 2011 to July 2013 in our hospital for treatment of 50 cases of type 2 diabetes mellitus with hypertension in elderly patients as the research object, according to the order of admission were divided into control group and observation group, 25 cases of Patients in the control group received irbesartan combined with loratadine, while those in the observation group received irbesartan plus levamlodipine. The therapeutic effects of the two groups were compared. Results: The decrease of blood pressure in the observation group was significantly higher than that in the control group, the difference was significant (P <0.05). Conclusion: Irbesartan combined with L-amlodipine in the clinical treatment of elderly patients with type 2 diabetes mellitus and hypertension can effectively reduce its blood pressure level and protect its renal function under the premise of ensuring the normal metabolism of patients , And significant effect, it is worth promoting.